SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy.

Dafsari, HS; Pemberton, JG; Ferrer, EA; Yammine, T; Farra, C; Mohammadi, MH; Ghayoor Karimiani, E; Hashemi, N; Souaid, M; Sabbagh, S; et al. Dafsari, HS; Pemberton, JG; Ferrer, EA; Yammine, T; Farra, C; Mohammadi, MH; Ghayoor Karimiani, E; Hashemi, N; Souaid, M; Sabbagh, S; Najarzadeh Torbati, P; Khan, S; Roze, E; Moreno-De-Luca, A; Bertoli-Avella, AM; Houlden, H; Balla, T; Maroofian, R (2022) PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy. Ann Clin Transl Neurol, 9 (9). pp. 1345-1358. ISSN 2328-9503 https://doi.org/10.1002/acn3.51634
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

OBJECTIVE: Intracellular signaling networks rely on proper membrane organization to control an array of cellular processes such as metabolism, proliferation, apoptosis, and macroautophagy in eukaryotic cells and organisms. Phosphatidylinositol 4-phosphate (PI4P) emerged as an essential regulatory lipid within organelle membranes that defines their lipid composition and signaling properties. PI4P is generated by four distinct phosphatidylinositol 4-kinases (PI4K) in mammalian cells: PI4KA, PI4KB, PI4K2A, PI4K2B. Animal models and human genetic studies suggest vital roles of PI4K enzymes in development and function of various organs, including the nervous system. Bi-allelic variants in PI4KA were recently associated with neurodevelopmental disorders (NDD), brain malformations, leukodystrophy, primary immunodeficiency, and inflammatory bowel disease. Here, we describe patients from two unrelated consanguineous families with PI4K2A deficiency and functionally explored the pathogenic mechanism. METHODS: Two patients with PI4K2A deficiency were identified by exome sequencing, presenting with developmental and epileptic-dyskinetic encephalopathy. Neuroimaging showed corpus callosum dysgenesis, diffuse white matter volume loss, and hypoplastic vermis. In addition to NDD, we observed recurrent infections and death at toddler age. We further explored identified variants with cellular assays. RESULTS: This clinical presentation overlaps with what was previously reported in two affected siblings with homozygous nonsense PI4K2A variant. Cellular studies analyzing these human variants confirmed their deleterious effect on PI4K2A activity and, together with the central role of PI4K2A in Rab7-associated vesicular trafficking, establish a link between late endosome-lysosome defects and NDD. INTERPRETATION: Our study establishes the genotype-phenotype spectrum of PI4K-associated NDD and highlights several commonalities with other innate errors of intracellular trafficking.

Item Type: Article
Additional Information: © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Epilepsy, Generalized, Homozygote, Humans, Minor Histocompatibility Antigens, Nervous System Malformations, Neurodevelopmental Disorders, Phosphotransferases (Alcohol Group Acceptor), Humans, Epilepsy, Generalized, Nervous System Malformations, Phosphotransferases (Alcohol Group Acceptor), Minor Histocompatibility Antigens, Homozygote, Neurodevelopmental Disorders, 1103 Clinical Sciences, 1109 Neurosciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Ann Clin Transl Neurol
ISSN: 2328-9503
Language: eng
Dates:
DateEvent
10 September 2022Published
25 July 2022Published Online
8 July 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDUniversity of CologneUNSPECIFIED
WT104033AIAWellcome Trusthttp://dx.doi.org/10.13039/100004440
WT093205Wellcome Trusthttp://dx.doi.org/10.13039/100004440
413543196Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
UNSPECIFIEDNational Institute of Child Health and Human Developmenthttp://dx.doi.org/10.13039/100000071
PubMed ID: 35880319
Web of Science ID: WOS:000829806300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114996
Publisher's version: https://doi.org/10.1002/acn3.51634

Actions (login required)

Edit Item Edit Item